Registration document 2007 - Total.com

9
The market value of the Group’s share in CEPSA amounted to 7,762 M€ as of December 31, 2006. The market value of the Group’s share
in Sanofi-Aventis amounted to 12,485 M€ as of December 31, 2006.
CEPSA
CONDENSED BALANCE SHEET
As of December 2006 (in M€)
Non-current assets 4,465 Shareholders’ equity 4,838
Current assets 4,259 Non-current liabilities 1,356
Current liabilities 2,530
Total 8,724 Total 8,724
INCOME STATEMENT INFORMATION
As of December 31, 2006 (in M€) 2006
Revenues 18,473
Consolidated net income, group share 812
Sanofi-Aventis
CONDENSED BALANCE SHEET
As of December 31, 2006 (in M€)
Non-current assets 65,603 Shareholders’ equity 45,820
Current assets 12,160 Non-current liabilities 21,665
Current liabilities 10,278
Total 77,763 Total 77,763
INCOME STATEMENT INFORMATION
As of December 31, 2006 (in M€) 2006
Revenues 28,373
Consolidated net incomes, group share 4,006
13) Other investments
As of December 31, 2006 (in M€) 2006 2005
Carrying Unrealized Balance Carrying Unrealized Balance
amount gain (loss) sheet value amount gain (loss) sheet value
I.C.E. (Inter Continental Exchange) (a) - - - 1 138 139
Santander Central Hispano (SCH) (a) - - - 93 88 181
Areva 69 135 204 69 79 148
Arkema 16 82 98 - - -
Other publicly traded equity securities 1 1 2 1 - 1
Total publicly traded equity security (b) 86 218 304 164 305 469
BBPP 80 - 80 89 - 89
Oman LNG LLC 6 - 6 7 - 7
BTC Limited 185 - 185 177 - 177
Other equity securities 675 - 675 774 - 774
Total other equity securities (b) 946 - 946 1,047 - 1,047
Other investments 1,032 218 1,250 1,211 305 1,516
(a) Shares sold in 2006.
(b) Including impairment for 668 M€ in 2006 and 820 M€ in 2005.
These investments are recognized under "Financial assets held for sales” (see note 1L to the consolidated financial statements).
200
Appendix 1 – Consolidated financial statements
Notes to the consolidated financial statement
TOTAL – Registration Document 2006